Analysts Viewpoint
A company insider recently sold 19,582 shares of CRISPR Therapeutics AG [CRSP]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
CRISPR Therapeutics AG’s filing revealed that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.17 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.17 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.45 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.45 million